CYTOSORBENTS CORPORATION (CTSO) Free cash flow 2016–2025
CYTOSORBENTS CORPORATION (CTSO) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$12.5MFY2025 · since FY2016: -$6.9M → -$12.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$12.5M | +14.8% |
| FY2024 | -$14.7M | +33.7% |
| FY2023 | -$22.2M | +35.3% |
| FY2022 | -$34.3M | -94.5% |
| FY2021 | -$17.6M | -179.1% |
| FY2020 | -$6.3M | +63.8% |
| FY2019 | -$17.5M | -51.6% |
| FY2018 | -$11.5M | -54.5% |
| FY2017 | -$7.5M | -8.4% |
| FY2016 | -$6.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice